Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Colorado Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Colorado Therapeutics

Colorado Therapeutics

Colorado Therapeutics develops xenogenic tissue matrix products for soft tissue reinforcement and regeneration.

HQ
Louisville, CO, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded in Broomfield, Colorado, Colorado Therapeutics specializes in developing xenogenic tissue matrix products aimed at soft tissue reinforcement and regeneration. The company's core mission is to advance medical technology through innovative biologic implants that enhance tissue repair and regenerative processes. Their flagship product, XI-S+™, is a lightweight biologic implant designed for a variety of soft tissue and vascular applications, targeting both the medical and surgical markets.

Notable affiliations include a license agreement with Micro Interventional Devices for the use of PolyCor™ Anchoring Technology. Colorado Therapeutics has achieved significant milestones in research and development, positioning itself as a leader in the biologic implant sector. The company's impact is marked by its contributions to improving patient outcomes in soft tissue repair and regenerative medicine.

Colorado Therapeutics - Similar Companies

TissueForm logo

TissueForm

tissueforminc.com

Snoasis Medical logo

Snoasis Medical

snoasismedical.com

Exogenesis logo

Exogenesis

Pegasus Biologics logo

Pegasus Biologics

pegasusbio.com

NeXtGen Biologics logo

NeXtGen Biologics

Histogen logo

Histogen

histogen.com

ECM Therapeutics logo

ECM Therapeutics

Xylos logo

Xylos

xyloscorp.com

NovoThelium logo

NovoThelium

novothelium.com

RegeneRx Biopharmaceuticals logo

RegeneRx Biopharmaceuticals

Circle Biologics logo

Circle Biologics

Endogena Therapeutics logo

Endogena Therapeutics

RegenX logo

RegenX

EndoCellutions logo

EndoCellutions

endocellutions.com

X-Cor Therapeutics logo

X-Cor Therapeutics

Colorado Therapeutics - Quick Facts

Who are Colorado Therapeutics' competitors?

Companies similar to Colorado Therapeutics include TissueForm, Snoasis Medical, Exogenesis and Pegasus Biologics.

When was Colorado Therapeutics founded?

Colorado Therapeutics was founded in 2015.

Where is Colorado Therapeutics' headquarters located?

Colorado Therapeutics' headquarters is located in Louisville, CO, US.

When was Colorado Therapeutics' last funding round?

Colorado Therapeutics' most recent funding round was for $2.6M (USD) in April 2017.

How much has Colorado Therapeutics raised to-date?

As of Apr 17, 2017, Colorado Therapeutics has raised a total of $6.9M (USD).

How many employees does Colorado Therapeutics have?

Colorado Therapeutics has 30 employees as of Feb 5, 2024.

Colorado Therapeutics - Classification

Industry
  • Hardware
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Biologic Implants
  • Tissue Products
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research